, Australia
/Freepik

QBE reports strong premium growth, up 10% YoY

The group’s performance was partially offset by short-tail prior-year development.

QBE's profit after tax more than doubled to $1.36b in 2023 from the $587m the previous year.

Premium growth remained strong, with gross written premium increasing by 10% year-on-year (YoY) driven by group-wide renewal rate hikes of 9.7% and targeted new business growth. 

The combined operating ratio improved to 95.2%, or 94.6% excluding upfront costs of a $1.9b reserve transaction completed in the first half. 

Favourable market conditions and current-year catastrophe experience supported these results, partially offset by short-tail prior-year development.

ALSO READ: QBE Insurance appoints Rob Kosova as Asia CEO

QBE's regulatory Prescribed Capital Amount (PCA) multiple improved to 1.82x from 1.79x at the end of 2022, remaining at the upper end of the group's target range of 1.6-1.8x. 

The board declared a final dividend of 48 Australian cents per share, up from 30 Australian cents per share in 2022. On top of that, basic earnings per share was 91.4 US cents, higher than the 44.8 US cents in 2022.

The 2023 dividend payout ratio of 45% of adjusted cash profit reflects the group's strong capital position and favourable growth outlook.

 

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.